Jordi Martorell1, Pablo Santomá2, Kumaran Kolandaivelu3, Vijaya B Kolachalama4, Pedro Melgar-Lesmes3, José J Molins5, Lawrence Garcia6, Elazer R Edelman7, Mercedes Balcells8. 1. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Chemical Engineering, IQS School of Engineering, URL, Via Augusta 390, 08017 Barcelona, Spain jordi.martorell@iqs.edu. 2. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Chemical Engineering, IQS School of Engineering, URL, Via Augusta 390, 08017 Barcelona, Spain. 3. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA. 4. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA Charles Stark Draper Laboratory, Cambridge, MA, USA. 5. Department of Chemical Engineering, IQS School of Engineering, URL, Via Augusta 390, 08017 Barcelona, Spain. 6. Department of Interventional Cardiology and Vascular Medicine, St. Elizabeth's Medical Center, Boston, MA, USA. 7. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 8. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA Department of Biological Engineering, IQS School of Engineering, URL, Barcelona, Spain.
Abstract
AIMS: Atherogenesis, evolution of plaque, and outcomes following endovascular intervention depend heavily on the unique vascular architecture of each individual. Patient-specific, multiscale models able to correlate changes in microscopic cellular responses with relevant macroscopic flow, and structural conditions may help understand the progression of occlusive arterial disease, providing insights into how to mitigate adverse responses in specific settings and individuals. METHODS AND RESULTS: Vascular architectures mimicking coronary and carotid bifurcations were derived from clinical imaging and used to generate conjoint computational meshes for in silico analysis and biocompatible scaffolds for in vitro models. In parallel with three-dimensional flow simulations, geometrically realistic scaffolds were seeded with human smooth muscle cells (SMC) or endothelial cells and exposed to relevant, physiological flows. In vitro surrogates of endothelial health, atherosclerotic progression, and thrombosis were locally quantified and correlated best with an quantified extent of flow recirculation occurring within the bifurcation models. Oxidized low-density lipoprotein uptake, monocyte adhesion, and tissue factor expression locally rose up to three-fold, and phosphorylated endothelial nitric oxide synthase and Krüppel-like factor 2 decreased up to two-fold in recirculation areas. Isolated testing in straight-tube idealized constructs subject to static, oscillatory, and pulsatile conditions, indicative of different recirculant conditions corroborated these flow-mediated dependencies. CONCLUSIONS: Flow drives variations in vascular reactivity and vascular beds. Endothelial health was preserved by arterial flow but jeopardized in regions of flow recirculation in a quasi-linear manner. Similarly, SMC exposed to flow were more thrombogenic in large recirculating regions. Health, thrombosis, and atherosclerosis biomarkers correlate with the extent of recirculation in vascular cells lining certain vascular geometries. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Atherogenesis, evolution of plaque, and outcomes following endovascular intervention depend heavily on the unique vascular architecture of each individual. Patient-specific, multiscale models able to correlate changes in microscopic cellular responses with relevant macroscopic flow, and structural conditions may help understand the progression of occlusive arterial disease, providing insights into how to mitigate adverse responses in specific settings and individuals. METHODS AND RESULTS: Vascular architectures mimicking coronary and carotid bifurcations were derived from clinical imaging and used to generate conjoint computational meshes for in silico analysis and biocompatible scaffolds for in vitro models. In parallel with three-dimensional flow simulations, geometrically realistic scaffolds were seeded with human smooth muscle cells (SMC) or endothelial cells and exposed to relevant, physiological flows. In vitro surrogates of endothelial health, atherosclerotic progression, and thrombosis were locally quantified and correlated best with an quantified extent of flow recirculation occurring within the bifurcation models. Oxidized low-density lipoprotein uptake, monocyte adhesion, and tissue factor expression locally rose up to three-fold, and phosphorylated endothelial nitric oxide synthase and Krüppel-like factor 2 decreased up to two-fold in recirculation areas. Isolated testing in straight-tube idealized constructs subject to static, oscillatory, and pulsatile conditions, indicative of different recirculant conditions corroborated these flow-mediated dependencies. CONCLUSIONS: Flow drives variations in vascular reactivity and vascular beds. Endothelial health was preserved by arterial flow but jeopardized in regions of flow recirculation in a quasi-linear manner. Similarly, SMC exposed to flow were more thrombogenic in large recirculating regions. Health, thrombosis, and atherosclerosis biomarkers correlate with the extent of recirculation in vascular cells lining certain vascular geometries. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: T Hozumi; K Yoshida; T Akasaka; Y Asami; Y Ogata; T Takagi; S Kaji; T Kawamoto; Y Ueda; S Morioka Journal: J Am Coll Cardiol Date: 1998-11 Impact factor: 24.094
Authors: Gillian Douglas; Erik Van Kampen; Ashley B Hale; Eileen McNeill; Jyoti Patel; Mark J Crabtree; Ziad Ali; Robert A Hoerr; Nicholas J Alp; Keith M Channon Journal: Eur Heart J Date: 2012-09-24 Impact factor: 29.983
Authors: Pedro Melgar-Lesmes; Alvaro Sánchez-Herrero; Ferran Lozano-Juan; Jose María de la Torre Hernández; Eulàlia Montell; Wladimiro Jiménez; Elazer R Edelman; Mercedes Balcells Journal: Thromb Haemost Date: 2018-06-06 Impact factor: 5.249
Authors: Elizabeth Le Master; Ru-Ting Huang; Chongxu Zhang; Yedida Bogachkov; Cassandre Coles; Tzu-Pin Shentu; Yue Sheng; Ibra S Fancher; Carlos Ng; Theodore Christoforidis; Pappasani V Subbaiah; Evgeny Berdyshev; Zhijian Qain; David T Eddington; James Lee; Michael Cho; Yun Fang; Richard D Minshall; Irena Levitan Journal: Arterioscler Thromb Vasc Biol Date: 2017-10-12 Impact factor: 8.311
Authors: Diego Gallo; Payam B Bijari; Umberto Morbiducci; Ye Qiao; Yuanyuan Joyce Xie; Maryam Etesami; Damiaan Habets; Edward G Lakatta; Bruce A Wasserman; David A Steinman Journal: J R Soc Interface Date: 2018-10-10 Impact factor: 4.118
Authors: Pauline Mury; Camille Faes; Antoine Millon; Mathilde Mura; Céline Renoux; Sarah Skinner; Virginie Nicaise; Philippe Joly; Nellie Della Schiava; Patrick Lermusiaux; Philippe Connes; Vincent Pialoux Journal: Front Physiol Date: 2017-12-12 Impact factor: 4.566